 - Has a known additional malignancy that has progressed or required active treatment within the last 5 years with the exception of curatively treated basal cell and squamous cell carcinoma of the skin andor curatively resected in-situ cervical andor breast cancers, and in-situ or intra-mucosal pharyngeal cancer 